Pfizer Inc. (PFE) Q4 2007 Earnings Results

Pfizer Beats on EPS, Stock Up 2.79%

Pfizer's earnings report shows a positive surprise in EPS, which likely contributed to the stock's 2.79% increase. Investors may view the strong EPS as a sign of resilience, even without revenue details. The lack of guidance could lead to some uncertainty about future performance, but the positive EPS surprise may bolster investor confidence in the company's direction.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.52	N/A	+10.64%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management highlighted their commitment to innovation and maintaining strong financial performance. They did not provide specific guidance for future quarters.

Management expressed satisfaction with the EPS results despite not providing revenue figures.

They emphasized ongoing efforts in research and development.

Pfizer Beats on EPS, Stock Up 2.79%

Key numbers

Management commentary

Pfizer Inc.

More earnings this week

Pfizer Beats on EPS, Stock Up 2.79%

Key numbers

Management commentary